FLT3 and acute myeloid leukemia: Additionally, Yılmaz et al. explored the efficacy of the triple combination of Quizartinib, Venetoclax (VEN), and decitabine (DAC) in R/R or newly diagnosed FLT3-ITDm AML patients.